JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kolesnikov, Y.
Right arrow Articles by Pasternak, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolesnikov, Y.
Right arrow Articles by Pasternak, G. W.

Vol. 290, Issue 1, 247-252, July 1999

Topical Opioids in Mice: Analgesia and Reversal of Tolerance by a Topical N-Methyl-D-Aspartate Antagonist1

Yuri Kolesnikov and Gavril W. Pasternak

Department of Anesthesiology (Y.K.) and The Cotzias Laboratory of Neuro-Oncology (G.W.P.), Memorial Sloan-Kettering Cancer Center; and the Departments of Pharmacology and Neurology and Neuroscience, Cornell University Medical College (G.W.P.), New York, New York

In addition to its central actions, morphine has important peripheral effects. To examine peripheral analgesic mechanisms, we developed a topical opioid paradigm in which the tail was immersed in a dimethyl sulfoxide (DMSO) solution containing various drugs. Alone, DMSO was inactive in the tail-flick assay in mice. DMSO solutions containing morphine and peptides such as [D-Ala2,MePhe4,Gly(ol)5]enkephalin (DAMGO) produced a potent, dose-dependent analgesia with the radiant heat tail-flick assay. The actions of the drugs were local. Analgesia was observed only in regions of the tail exposed to the solution and not in more proximal unexposed portions of the tail. Immersion of the tail in a solution containing either 125I-labeled morphine or 125I-labeled DAMGO revealed no detectable uptake of radioactivity into the brain, spinal cord, or blood. In the tail, radioactivity was limited only to the regions actually immersed in the solutions. The topical drugs potentiated systemic agents, similar to the previously established synergy between peripheral and central sites of action. Local tolerance was rapidly produced by repeated daily exposure of the tail to morphine. Topical morphine tolerance was effectively blocked by the N-methyl-D-aspartate (NMDA) antagonist MK801 given either systemically or topically but not intrathecally. The ability of a topical NMDA antagonist to block local morphine tolerance suggests that peripheral NMDA receptors mediate topical morphine tolerance. Morphine was cross-tolerant to DAMGO, but not to morphine-6beta -glucuronide, implying different mechanisms of action. These observations are significant in the design and use of opioids clinically.

0022-3565/99/2901-0247$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego
The Endomorphin System and Its Evolving Neurophysiological Role
Pharmacol. Rev., March 1, 2007; 59(1): 88 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Ji, A. Z. Murphy, and R. J. Traub
Sex differences in morphine-induced analgesia of visceral pain are supraspinally and peripherally mediated
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R307 - R314.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. T. Whiteside, J. E. Harrison, M. S. Pearson, Z. Chen, Y. Rotshteyn, P. I. Turchin, J. D. Pomonis, L. Mark, K. Walker, and K. C. Brogle
DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a Novel, Systemically Available, and Peripherally Restricted Mu Opioid Agonist with Antihyperalgesic Activity: II. In Vivo Pharmacological Characterization in the Rat
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 793 - 799.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
G Watterson, R Howard, and A Goldman
Peripheral opioids in inflammatory pain
Arch. Dis. Child., July 1, 2004; 89(7): 679 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y. A. Kolesnikov, R. S. Wilson, and G. W. Pasternak
The Synergistic Analgesic Interactions Between Hydrocodone and Ibuprofen
Anesth. Analg., December 1, 2003; 97(6): 1721 - 1723.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y. A. Kolesnikov, M. Cristea, and G. W. Pasternak
Analgesic Synergy Between Topical Morphine and Butamben in Mice
Anesth. Analg., October 1, 2003; 97(4): 1103 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
J. Sawynok
Topical and Peripherally Acting Analgesics
Pharmacol. Rev., March 1, 2003; 55(1): 1 - 20.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
I. Kissin, C. A. Bright, and E. L. Bradley Jr.
Can Inflammatory Pain Prevent the Development of Acute Tolerance to Alfentanil?
Anesth. Analg., May 1, 2001; 92(5): 1296 - 1300.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y. A. Kolesnikov, I. Chereshnev, and G. W. Pasternak
Analgesic Synergy between Topical Lidocaine and Topical Opioids
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 546 - 551.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.